MANNKIND CORP's ticker is MNKDXXXX and the CUSIP is 56400P201. A total of 137 filers reported holding MANNKIND CORP in Q2 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $318,000 | +14.8% | 499,940 | +11.9% | 0.00% | – |
| Q3 2016 | $277,000 | -52.8% | 446,740 | -11.8% | 0.00% | -100.0% |
| Q2 2016 | $587,000 | -11.3% | 506,225 | +23.0% | 0.00% | 0.0% |
| Q1 2016 | $662,000 | +4.6% | 411,425 | -5.8% | 0.00% | 0.0% |
| Q4 2015 | $633,000 | -55.4% | 436,540 | -1.3% | 0.00% | 0.0% |
| Q3 2015 | $1,420,000 | -43.7% | 442,280 | -0.1% | 0.00% | -50.0% |
| Q2 2015 | $2,520,000 | +9.4% | 442,840 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $2,303,000 | -0.3% | 442,840 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,309,000 | -11.8% | 442,840 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $2,617,000 | -46.1% | 442,840 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $4,854,000 | +216.4% | 442,840 | +16.1% | 0.00% | +300.0% |
| Q1 2014 | $1,534,000 | +5.6% | 381,506 | +36.9% | 0.00% | 0.0% |
| Q4 2013 | $1,452,000 | -9.2% | 278,606 | -0.7% | 0.00% | -50.0% |
| Q3 2013 | $1,599,000 | -28.9% | 280,545 | -18.9% | 0.00% | 0.0% |
| Q2 2013 | $2,248,000 | – | 345,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greywolf Capital Management LP | 7,206,570 | $37,582,000 | 6.66% |
| AYM CAPITAL, LLC | 1,417,300 | $7,392,000 | 5.50% |
| AYM CAPITAL, LLC | 655,000 | $3,416,000 | 2.54% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,810,250 | $9,440,000 | 2.51% |
| Beach Point Capital Management LP | 1,902,100 | $9,919,000 | 2.37% |
| Cohen Capital Management, Inc. | 503,000 | $2,623,000 | 0.68% |
| Tourbillon Capital Partners, L.P. | 3,300,000 | $17,210,000 | 0.46% |
| EQUITEC SPECIALISTS, LLC | 288,700 | $1,504,000 | 0.39% |
| Old West Investment Management, LLC | 116,676 | $608,000 | 0.38% |
| Adamant Biomedical Investments AG | 300,000 | $1,564,000 | 0.37% |